Remote video URL
11-minute watch
| Talk 5
of 8
EHA: Navigating CAR T in 2L DLBCL
How has CAR T changed the second-line DLBCL treatment landscape? Further studies
Prof. Bertram Glaß
Helios Hospital Berlin-Buch, Berlin, Germany
Prof. Bertram Glaß, Helios Hospital Berlin-Buch, Berlin, Germany, reports findings from clinical studies such as the TRANSFORM, ALYCANTE and PILOT trials and uncovers how CAR T-cell therapy has changed the R/R DLBCL treatment landscape
Read more
Talks in this series
Interested in this topic?
×
We value your feedback to help us improve and inform future materials
Please select a star rating out of 5 stat best describes your experience of this content
(1 = low; 5 = high)